Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CIRSE Registry for SIR-Spheres in France (CIRT-FR)

NCT: NCT03256994 · COMPLETED

NCT IDNCT03256994
StatusCOMPLETED
Start Date2017-08-01
Completion2022-07-31

Brief Summary

Selective Internal Radiation Therapy (SIRT), also known as radioembolisation, is a minimal invasive, endovascular treatment for primary and secondary liver tumours. In France, SIR-Spheres are listed as reimbursable by the national health authorities (Haute Autorité de Santé \[HAS\]). In order to evaluate the reimbursement after five years, all patients treated with SIR-Spheres will be entered into a registry that collects data on the real-life clinical application of SIRT and reports to the national authorities.

Frequently Asked Questions

What is CIRSE Registry for SIR-Spheres in France (CIRT-FR)?

CIRSE Registry for SIR-Spheres in France (CIRT-FR) is a clinical trial registered under NCT03256994. Current status: COMPLETED.

What is the status of NCT03256994?

The current status of NCT03256994 (CIRSE Registry for SIR-Spheres in France (CIRT-FR)) is: COMPLETED.

When did CIRSE Registry for SIR-Spheres in France (CIRT-FR) start?

CIRSE Registry for SIR-Spheres in France (CIRT-FR) started on 2017-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.